首页> 美国卫生研究院文献>JNMA: Journal of the Nepal Medical Association >Clinical Profile of COVID-19 in Children and Research Progress on Angiotensin-converting Enzyme 2: A Mini-review
【2h】

Clinical Profile of COVID-19 in Children and Research Progress on Angiotensin-converting Enzyme 2: A Mini-review

机译:Covid-19儿童Covid-19的临床剖面和血管紧张素转化酶的研究进展2:迷你评论

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The cases of coronavirus disease 2019 in children have been increasing with the ongoing pandemic. The finding suggests children have mild symptoms and a short course of the disease. Angiotensinconverting enzyme-2 mediates entry of the virus into the cell, the combination of virus and ACE2 leads to an increase in activity of angiotensin II, resulting in acute injury to lungs, myocardium and other organs. The infection causes down-regulation of ACE2 expression. The ACE2 plays an important role in the infection progression and clinical characteristics of COVID-19. Works on ACE2 and virus spike protein have future prospects of strategic information on prevention, management as well as vaccine development.
机译:2019年儿童冠状病毒疾病的病例一直在持续的大流行增加。该发现表明儿童有轻微的症状和疾病的短期。血管紧张素酶-2介导病毒进入细胞,病毒和ACE2的组合导致血管紧张素II的活性增加,导致肺,心肌和其他器官急性损伤。感染导致ACE2表达的下调。 ACE2在Covid-19的感染进展和临床特征中起重要作用。在ACE2和病毒尖峰蛋白上的作品具有预防,管理以及疫苗开发的未来战略信息的未来前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号